Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-17

FDA Approved: AMLODIPINE AND VALSARTAN — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for a generic amlodipine and valsartan combination tablet by Alembic Pharmaceuticals Limited. This approval allows t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMLODIPINE AND VALSARTAN (amlodipine and valsartan)

Snippet

SUPPL AP for AMLODIPINE AND VALSARTAN (AMLODIPINE AND VALSARTAN)